IDEXX Laboratories, Inc. (0J8P.L)
USD 372.49
(0.37%)
USD 372.49
(0.37%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 622.88 Million USD | -10.3% |
| 2022 | 694.38 Million USD | -10.43% |
| 2021 | 775.2 Million USD | -9.7% |
| 2020 | 858.49 Million USD | 22.83% |
| 2019 | 698.91 Million USD | 16.22% |
| 2018 | 601.34 Million USD | -0.78% |
| 2017 | 606.07 Million USD | 2.19% |
| 2016 | 593.11 Million USD | -0.67% |
| 2015 | 597.08 Million USD | 70.6% |
| 2014 | 350 Million USD | 132.78% |
| 2013 | 150.35 Million USD | 10686.15% |
| 2012 | 1.39 Million USD | -44.26% |
| 2011 | 2.5 Million USD | -26.83% |
| 2010 | 3.41 Million USD | -20.16% |
| 2009 | 4.28 Million USD | -15.96% |
| 2008 | 5.09 Million USD | -11.05% |
| 2007 | 5.72 Million USD | -11.17% |
| 2006 | 6.44 Million USD | 182.59% |
| 2005 | -7.8 Million USD | -2091.33% |
| 2004 | 392 Thousand USD | -50.13% |
| 2003 | 786 Thousand USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | -100.0% |
| 1999 | 300 Thousand USD | -92.86% |
| 1998 | 4.2 Million USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 724.65 Million USD | 16.34% |
| 2024 Q2 | 524.74 Million USD | -27.59% |
| 2024 Q3 | 524.75 Million USD | 0.0% |
| 2023 Q2 | 696.84 Million USD | 0.07% |
| 2023 Q3 | 618.81 Million USD | -11.2% |
| 2023 Q4 | 622.88 Million USD | 0.66% |
| 2023 Q1 | 696.36 Million USD | 0.28% |
| 2023 FY | 622.88 Million USD | -10.3% |
| 2022 Q4 | 694.38 Million USD | -18.68% |
| 2022 Q3 | 853.94 Million USD | 11.19% |
| 2022 FY | 694.38 Million USD | -10.43% |
| 2022 Q1 | 863.01 Million USD | 11.33% |
| 2022 Q2 | 767.99 Million USD | -11.01% |
| 2021 Q2 | 780.07 Million USD | -8.97% |
| 2021 Q3 | 867.74 Million USD | 11.24% |
| 2021 Q4 | 775.2 Million USD | -10.66% |
| 2021 FY | 775.2 Million USD | -9.7% |
| 2021 Q1 | 856.94 Million USD | -0.18% |
| 2020 Q4 | 858.49 Million USD | -7.09% |
| 2020 Q2 | 968.15 Million USD | 26.94% |
| 2020 FY | 858.49 Million USD | 22.83% |
| 2020 Q1 | 762.7 Million USD | 9.13% |
| 2020 Q3 | 923.97 Million USD | -4.56% |
| 2019 Q3 | 762.97 Million USD | -0.9% |
| 2019 FY | 698.91 Million USD | 16.22% |
| 2019 Q1 | 768.28 Million USD | 27.76% |
| 2019 Q2 | 769.88 Million USD | 0.21% |
| 2019 Q4 | 698.91 Million USD | -8.4% |
| 2018 FY | 601.34 Million USD | -0.78% |
| 2018 Q1 | 609 Million USD | 0.48% |
| 2018 Q2 | 603.13 Million USD | -0.96% |
| 2018 Q3 | 602.41 Million USD | -0.12% |
| 2018 Q4 | 601.34 Million USD | -0.18% |
| 2017 Q3 | 604.14 Million USD | 0.54% |
| 2017 Q1 | 594.86 Million USD | 0.3% |
| 2017 Q4 | 606.07 Million USD | 0.32% |
| 2017 Q2 | 600.89 Million USD | 1.01% |
| 2017 FY | 606.07 Million USD | 2.19% |
| 2016 Q1 | 600.02 Million USD | 0.49% |
| 2016 Q4 | 593.11 Million USD | -1.01% |
| 2016 Q3 | 599.13 Million USD | 0.2% |
| 2016 FY | 593.11 Million USD | -0.67% |
| 2016 Q2 | 597.95 Million USD | -0.34% |
| 2015 Q3 | 599.55 Million USD | 0.11% |
| 2015 FY | 597.08 Million USD | 70.6% |
| 2015 Q2 | 598.92 Million USD | 19.79% |
| 2015 Q1 | 500 Million USD | 42.86% |
| 2015 Q4 | 597.08 Million USD | -0.41% |
| 2014 Q1 | 150.09 Million USD | -0.18% |
| 2014 FY | 350 Million USD | 132.78% |
| 2014 Q4 | 350 Million USD | 0.0% |
| 2014 Q3 | 350 Million USD | 133.33% |
| 2014 Q2 | 150 Million USD | -0.06% |
| 2013 FY | 150.35 Million USD | 10686.15% |
| 2013 Q3 | 624 Thousand USD | -29.41% |
| 2013 Q2 | 884 Thousand USD | -22.52% |
| 2013 Q1 | 1.14 Million USD | -18.15% |
| 2013 Q4 | 150.35 Million USD | 23995.99% |
| 2012 FY | 1.39 Million USD | -44.26% |
| 2012 Q2 | 2.02 Million USD | -10.69% |
| 2012 Q3 | 1.77 Million USD | -12.12% |
| 2012 Q1 | 2.26 Million USD | -9.52% |
| 2012 Q4 | 1.39 Million USD | -21.51% |
| 2011 Q4 | 2.5 Million USD | -8.56% |
| 2011 Q2 | 2.96 Million USD | -7.14% |
| 2011 Q1 | 3.19 Million USD | -6.55% |
| 2011 FY | 2.5 Million USD | -26.83% |
| 2011 Q3 | 2.73 Million USD | -7.79% |
| 2010 Q1 | 4.07 Million USD | -4.93% |
| 2010 FY | 3.41 Million USD | -20.16% |
| 2010 Q3 | 3.63 Million USD | -5.63% |
| 2010 Q4 | 3.41 Million USD | -6.07% |
| 2010 Q2 | 3.85 Million USD | -5.26% |
| 2009 FY | 4.28 Million USD | -15.96% |
| 2009 Q1 | 4.89 Million USD | -3.89% |
| 2009 Q2 | 84.69 Million USD | 1629.86% |
| 2009 Q3 | 84.48 Million USD | -0.24% |
| 2009 Q4 | 4.28 Million USD | -94.93% |
| 2008 Q2 | 5.35 Million USD | -3.43% |
| 2008 Q1 | 5.54 Million USD | -3.27% |
| 2008 FY | 5.09 Million USD | -11.05% |
| 2008 Q4 | 5.09 Million USD | -1.22% |
| 2008 Q3 | 5.15 Million USD | -3.61% |
| 2007 Q2 | 6.09 Million USD | -2.85% |
| 2007 FY | 5.72 Million USD | -11.17% |
| 2007 Q1 | 6.27 Million USD | -2.73% |
| 2007 Q3 | 5.91 Million USD | -2.97% |
| 2007 Q4 | 5.72 Million USD | -3.11% |
| 2006 Q3 | 6.62 Million USD | -2.5% |
| 2006 FY | 6.44 Million USD | 182.59% |
| 2006 Q4 | 6.44 Million USD | -2.69% |
| 2006 Q1 | -7.17 Million USD | 8.1% |
| 2006 Q2 | 6.79 Million USD | 194.72% |
| 2005 Q1 | -6.44 Million USD | -1744.64% |
| 2005 Q2 | -6.85 Million USD | -6.34% |
| 2005 Q3 | -6.82 Million USD | 0.42% |
| 2005 Q4 | -7.8 Million USD | -14.34% |
| 2005 FY | -7.8 Million USD | -2091.33% |
| 2004 FY | 392 Thousand USD | -50.13% |
| 2004 Q4 | 392 Thousand USD | -21.6% |
| 2004 Q3 | 500 Thousand USD | 0.0% |
| 2004 Q1 | 653 Thousand USD | -16.92% |
| 2004 Q2 | 500 Thousand USD | -23.43% |
| 2003 Q4 | 786 Thousand USD | 115.35% |
| 2003 FY | 786 Thousand USD | 0.0% |
| 2003 Q1 | -5.71 Million USD | 0.0% |
| 2003 Q2 | -5.3 Million USD | 7.21% |
| 2003 Q3 | -5.12 Million USD | 3.47% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 FY | - USD | -100.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q1 | - USD | -100.0% |
| 1999 Q1 | 4.2 Million USD | 0.0% |
| 1999 Q2 | 4.2 Million USD | 0.0% |
| 1999 FY | 300 Thousand USD | -92.86% |
| 1999 Q3 | 4.2 Million USD | 0.0% |
| 1999 Q4 | 300 Thousand USD | -92.86% |
| 1998 Q4 | 4.2 Million USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 FY | 4.2 Million USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -30299.366% |
| Accuray Incorporated | 164.4 Million USD | -278.883% |
| Align Technology, Inc. | 96.96 Million USD | -542.359% |
| Elevance Health Inc. | 23.24 Billion USD | 97.32% |
| AxoGen, Inc. | 46.6 Million USD | -1236.573% |
| Boston Scientific Corporation | 8.56 Billion USD | 92.728% |
| CVS Health Corporation | 74.67 Billion USD | 99.166% |
| Cardinal Health, Inc. | 4.58 Billion USD | 86.409% |
| Centene Corporation | 17.69 Billion USD | 96.481% |
| DaVita Inc. | 8.05 Billion USD | 92.264% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 98.299% |
| Hologic, Inc. | 2.49 Billion USD | 75.056% |
| Humana Inc. | 10.21 Billion USD | 93.901% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | 84.638% |
| Masimo Corporation | 871.7 Million USD | 28.544% |
| McKesson Corporation | 5.45 Billion USD | 88.573% |
| Patterson Companies, Inc. | 328.91 Million USD | -89.377% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | 85.876% |
| ResMed Inc. | 697.31 Million USD | 10.674% |
| Henry Schein, Inc. | 1.93 Billion USD | 67.776% |
| Teladoc Health, Inc. | 1.58 Billion USD | 60.615% |
| Universal Health Services, Inc. | 4.71 Billion USD | 86.793% |
| Veeva Systems Inc. | 46.44 Million USD | -1241.235% |
| Baxter International Inc. | 11.06 Billion USD | 94.37% |
| Becton, Dickinson and Company | 14.73 Billion USD | 95.774% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 858.688% |
| Danaher Corporation | 17.66 Billion USD | 96.473% |
| Stryker Corporation | 10.9 Billion USD | 94.286% |
| Medtronic plc | 23.87 Billion USD | 97.391% |